» Authors » Tilman Bostel

Tilman Bostel

Explore the profile of Tilman Bostel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 791
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pollul G, Grossmann S, Karle H, Bostel T, Schmidberger H
J Appl Clin Med Phys . 2025 Mar; :e70041. PMID: 40022457
Background: To assess the dose-sparing capabilities of a yaw-limited volumetric modulated arc therapy (YL_VMAT) beam setup for adjacent organs at risk (OAR) in comparison with 3D-conventional radiation therapy (3D-CRT), intensity-modulated...
2.
Bostel T, Nikolaidou E, Wollschlager D, Mayer A, Kaufmann J, Hopprich A, et al.
Radiat Oncol . 2024 Mar; 19(1):28. PMID: 38433231
Background: To assess the tolerability and oncological results of chemoradiation in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction. Methods: This multi-center retrospective analysis included 86...
3.
Kaufmann J, Taubl A, Nikolaidou E, Ruhle A, Hopprich A, Wollschlager D, et al.
Strahlenther Onkol . 2024 Jan; 200(7):633-641. PMID: 38289360
Purpose: Multiple myeloma is associated with osteolytic bone lesions, often requiring surgery of the spine and postoperative radiotherapy (RT). Although common, data for clinical and informed decision-making are sparse. In...
4.
Bostel T, Akbaba S, Wollschlager D, Mayer A, Nikolaidou E, Murnik M, et al.
Front Oncol . 2023 Mar; 13:1063670. PMID: 36937445
Background And Purpose: To evaluate the tolerability and outcomes of chemoradiation in elderly patients with locally advanced esophageal squamous cell carcinoma (ESCC). Materials And Methods: This multi-center retrospective analysis included...
5.
Schroder C, Tang H, Windisch P, Zwahlen D, Buchali A, Vu E, et al.
Cancers (Basel) . 2022 Feb; 14(3). PMID: 35158961
(1) Background: Prostate cancer is the most common cancer in men and can be treated with radical prostatectomy (RPE) or radiotherapy in the primary setting. Stereotactic radiotherapy (SBRT) has proven...
6.
Mayer A, Wenzel W, Wollschlager D, Bostel T, Kruger M, Matthias C, et al.
Strahlenther Onkol . 2022 Jan; 198(2):159-170. PMID: 35037950
Purpose: About one fifth of patients with head and neck cancer are aged 70 years and older at the time of diagnosis. In these patients, risk factors (R1 status or...
7.
Bostel T, Akbaba S, Wollschlager D, Klodt T, Oebel L, Mayer A, et al.
Front Oncol . 2021 Nov; 11:753768. PMID: 34737961
Background And Purpose: To compare two validated spinal instability scores regarding the stabilizing effects and skeletal-related events (SREs) of palliative radiotherapy (RT) in patients with spinal bone metastases (SBM). Materials...
8.
Niebuhr N, Splinter M, Bostel T, Seco J, Hentschke C, Floca R, et al.
Radiat Oncol . 2021 Apr; 16(1):65. PMID: 33823885
Background: This work addresses a basic inconsistency in the way dose is accumulated in radiotherapy when predicting the biological effect based on the linear quadratic model (LQM). To overcome this...
9.
Foerster R, Zwahlen D, Buchali A, Tang H, Schroeder C, Windisch P, et al.
Cancers (Basel) . 2021 Mar; 13(4). PMID: 33673077
Background: Radiotherapy (RT) is an established, potentially curative treatment option for all risk constellations of localized prostate cancer (PCA). Androgen deprivation therapy (ADT) and dose-escalated RT can further improve outcome...
10.
Akbaba S, Ruhle A, Rothhaar S, Zamboglou C, Gkika E, Foerster R, et al.
Radiother Oncol . 2020 Dec; 156:266-274. PMID: 33359662
Background And Purpose: To evaluate oncological outcomes and treatment-related toxicities of elderly salivary gland cancer patients undergoing (chemo)radiotherapy. Material And Methods: Local/locoregional control (LRC), progression-free survival (PFS) and overall survival...